Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement

Recruiting now

Conditions studied: Autism, Infant Development

In brief

The goal of this project is to measure the clinical utility of an objective and quantitative eye-tracking assay collected on a standalone, mobile investigational device to accurately screen 9-month-old infants for autism spectrum disorder and other actionable delays.

Key facts

Study ID

NCT05916430

Run by

Emory University

People needed

2120

Starts

2023-02-02

Expected to finish

2027-12-01

Last updated by the study team

2026-06-04

Who can join

Age: 1 and older, up to 1. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Infants between the chronological ages of 8-10 months
• Infants must be generally healthy with no acute illnesses likely to prevent successful or valid data collection (e.g., current vomiting, high fever, conjunctivitis affecting vision)
• Participants' parents/caregivers must be able to understand and voluntarily provide written informed consent.

You may not qualify if…

• Children will be excluded if they have signs of acute illness likely to prevent successful or valid data collection (e.g., conjunctivitis affecting vision, current vomiting, or high fever).

Where it is running

• Children's Healthcare of Atlanta — Atlanta, Georgia, United States (enrolling)
• Emory University — Atlanta, Georgia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.